Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

NCT04962958 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma
Carcinoma, Hepatocellular
Liver Neoplasms
Digestive System Neoplasms
Antineoplastic Agents
Donafenib
Fluorouracil
Oxaliplatin
Antimetabolites

Interventions

PROCEDURE: Hepatic arterial infusion chemotherapy
DRUG: Folfox Protocol
DRUG: Donafenib

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborators

[object Object]
[object Object]
[object Object]